Abstract
An 83-year-old female had asymptomatic SARS-CoV-2 infection while taking ruxolitinib. She remained RT-PCR positive for viral RNA for >120 days, and Pegylated interferon for 4 weeks led to viral RNA clearance. The observations support combination therapy of ruxolitinib + interferon for COVID-19.
Original language | English (US) |
---|---|
Pages (from-to) | 2228-2235 |
Number of pages | 8 |
Journal | Clinical Case Reports |
Volume | 9 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2021 |
Externally published | Yes |
Keywords
- COVID-19
- interferon
- ruxolitinib
ASJC Scopus subject areas
- General Medicine